[1]
G. Caldarola, “Long-Term Effectiveness of Brodalumab for the Treatment of Moderate-To-Severe Psoriasis: A Real-Life Multicenter Study of Up to 3 Years in a Real-Life Italian Cohort”, Dermatol Pract Concept, vol. 14, no. 2, p. e2024152, Apr. 2024, doi: 10.5826/dpc.1402a152.